Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	74
Overall Study	STARTED	SD-809 12 mg/Day	75
Overall Study	STARTED	SD-809 24 mg/Day	74
Overall Study	STARTED	SD-809 36 mg/Day	75
Overall Study	Safety Population	Placebo	72
Overall Study	Safety Population	SD-809 12 mg/Day	74
Overall Study	Safety Population	SD-809 24 mg/Day	73
Overall Study	Safety Population	SD-809 36 mg/Day	74
Overall Study	Modified Intent to Treat Pop (mITT)	Placebo	58
Overall Study	Modified Intent to Treat Pop (mITT)	SD-809 12 mg/Day	60
Overall Study	Modified Intent to Treat Pop (mITT)	SD-809 24 mg/Day	49
Overall Study	Modified Intent to Treat Pop (mITT)	SD-809 36 mg/Day	55
Overall Study	COMPLETED	Placebo	67
Overall Study	COMPLETED	SD-809 12 mg/Day	67
Overall Study	COMPLETED	SD-809 24 mg/Day	65
Overall Study	COMPLETED	SD-809 36 mg/Day	65
Overall Study	NOT COMPLETED	Placebo	7
Overall Study	NOT COMPLETED	SD-809 12 mg/Day	8
Overall Study	NOT COMPLETED	SD-809 24 mg/Day	9
Overall Study	NOT COMPLETED	SD-809 36 mg/Day	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02291861/flow